Schedule 13D ownership disclosure
SYNTA PHARMACEUTICALS CORP
Security class unavailable · CUSIP: 87162T206
Event date: 2015-11-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-15-008353
- Form type
- SC 13D
- Filer
- CxSynta LLC
- CIK
- CIK 1388171
- Filed
- Nov 23, 2015
- Reporting period
- Nov 18, 2015
- Description
- Schedule 13D beneficial ownership